Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Jan;71(1):48–51. doi: 10.1038/bjc.1995.10

Clomiphene citrate reduces procarbazine-induced sterility in a rat model.

R Weissenberg 1, M Lahav 1, P Raanani 1, R Singer 1, A Regev 1, M Sagiv 1, S Giler 1, E Theodor 1
PMCID: PMC2033459  PMID: 7819047

Abstract

Chemotherapy with the cytotoxic drug procarbazine (PCB) causes permanent infertility in most male patients. Since many patients treated with this cytotoxic drug are of reproductive age, it is important to develop a method to protect spermatogenesis and fertility. It has been hypothesised that 'spermatogenic arrest' by pharmacological intervention may render the testes less susceptible to the effects of chemotherapy. The present study investigated whether recovery of fertility in a male rat model could be achieved by suppression of spermatogenesis with high doses of clomiphene citrate (CC) prior to PCB administration. It was demonstrated that young male rats treated with a combination of CC and PCB partially recovered spermatogenesis and achieved almost normal fertility. In contrast, animals treated with PCB alone exhibited abnormal spermatogenesis and remained infertile.

Full text

PDF
48

Images in this article

49Figure 1
on p.49
49Figure 2
on p.49
49Figure 3
on p.49
50Figure 4
on p.50

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Delic J. I., Bush C., Peckham M. J. Protection from procarbazine-induced damage of spermatogenesis in the rat by androgen. Cancer Res. 1986 Apr;46(4 Pt 2):1909–1914. [PubMed] [Google Scholar]
  2. Drasga R. E., Einhorn L. H., Williams S. D., Patel D. N., Stevens E. E. Fertility after chemotherapy for testicular cancer. J Clin Oncol. 1983 Mar;1(3):179–183. doi: 10.1200/JCO.1983.1.3.179. [DOI] [PubMed] [Google Scholar]
  3. Fairley K. F., Barrie J. U., Johnson W. Sterility and testicular atrophy related to cyclophosphamide therapy. Lancet. 1972 Mar 11;1(7750):568–569. doi: 10.1016/s0140-6736(72)90358-3. [DOI] [PubMed] [Google Scholar]
  4. Flickinger C. J. Effects of clompihene on the structure of the testis, epididymis and sex accessory glands of the rat. Am J Anat. 1977 Aug;149(4):533–561. doi: 10.1002/aja.1001490408. [DOI] [PubMed] [Google Scholar]
  5. Glode L. M., Robinson J., Gould S. F. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet. 1981 May 23;1(8230):1132–1134. doi: 10.1016/s0140-6736(81)92301-1. [DOI] [PubMed] [Google Scholar]
  6. Heller C. G., Rowley M. J., Heller G. V. Clomiphene citrate: a correlation of its effect on sperm concentration and morphology, total gonadotropins, ICSH, estrogen and testosterone excretion, and testicular cytology in normal men. J Clin Endocrinol Metab. 1969 May;29(5):638–649. doi: 10.1210/jcem-29-5-638. [DOI] [PubMed] [Google Scholar]
  7. Hollinger M. A. Effect of clomiphene on testicular protein synthesis in vitro. Biochem Pharmacol. 1970 Oct;19(10):2701–2705. doi: 10.1016/0006-2952(70)90096-1. [DOI] [PubMed] [Google Scholar]
  8. Hollinger M. A., Hwang F. Effect of in vivo and in vitro administration of clomiphene on RNA synthesis in rat testis. Arch Int Pharmacodyn Ther. 1972 Jun;197(2):213–221. [PubMed] [Google Scholar]
  9. Johnson D. H., Linde R., Hainsworth J. D., Vale W., Rivier J., Stein R., Flexner J., Van Welch R., Greco F. A. Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations. Blood. 1985 Apr;65(4):832–836. [PubMed] [Google Scholar]
  10. Jégou B., Velez de la Calle J. F., Bauché F. Protective effect of medroxyprogesterone acetate plus testosterone against radiation-induced damage to the reproductive function of male rats and their offspring. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8710–8714. doi: 10.1073/pnas.88.19.8710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Karashima T., Zalatnai A., Schally A. V. Protective effects of analogs of luteinizing hormone-releasing hormone against chemotherapy-induced testicular damage in rats. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2329–2333. doi: 10.1073/pnas.85.7.2329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lewis R. W., Dowling K. J., Schally A. V. D-Tryptophan-6 analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons. Proc Natl Acad Sci U S A. 1985 May;82(9):2975–2979. doi: 10.1073/pnas.82.9.2975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Meistrich M. L., Wilson G., Ye W. S., Kurdoglu B., Parchuri N., Terry N. H. Hormonal protection from procarbazine-induced testicular damage is selective for survival and recovery of stem spermatogonia. Cancer Res. 1994 Feb 15;54(4):1027–1034. [PubMed] [Google Scholar]
  14. Morris I. D., Bardin C. W., Gunsalus G., Ward J. A. Prolonged suppression of spermatogenesis by oestrogen does not preserve the seminiferous epithelium in procarbazine-treated rats. Int J Androl. 1990 Jun;13(3):180–189. doi: 10.1111/j.1365-2605.1990.tb00975.x. [DOI] [PubMed] [Google Scholar]
  15. Morris I. D., Shalet S. M. Protection of gonadal function from cytotoxic chemotherapy and irradiation. Baillieres Clin Endocrinol Metab. 1990 Mar;4(1):97–118. doi: 10.1016/s0950-351x(05)80318-0. [DOI] [PubMed] [Google Scholar]
  16. Nseyo U. O., Huben R. P., Klioze S. S., Pontes J. E. Protection of germinal epithelium with luteinizing hormone-releasing hormone analogue. J Urol. 1985 Jul;134(1):187–190. doi: 10.1016/s0022-5347(17)47054-6. [DOI] [PubMed] [Google Scholar]
  17. Papadopoulos I. LHRH analogues do not protect the germinal epithelium during chemotherapy. An experimental animal investigation. Urol Res. 1991;19(1):31–34. doi: 10.1007/BF00294018. [DOI] [PubMed] [Google Scholar]
  18. Parchuri N., Wilson G., Meistrich M. L. Protection by gonadal steroid hormones against procarbazine-induced damage to spermatogenic function in LBNF1 hybrid rats. J Androl. 1993 Jul-Aug;14(4):257–266. [PubMed] [Google Scholar]
  19. Pennisi A. J., Grushkin C. M., Lieberman E. Gonadal function in children with nephrosis treated with cyclophosphamide. Am J Dis Child. 1975 Mar;129(3):315–318. doi: 10.1001/archpedi.1975.02120400027006. [DOI] [PubMed] [Google Scholar]
  20. Roeser H. P., Stocks A. E., Smith A. J. Testicular damage due to cytotoxic drugs and recovery after cessation of therapy. Aust N Z J Med. 1978 Jun;8(3):250–254. doi: 10.1111/j.1445-5994.1978.tb04518.x. [DOI] [PubMed] [Google Scholar]
  21. Schilsky R. L., Lewis B. J., Sherins R. J., Young R. C. Gonadal dysfunction in patients receiving chemotherapy for cancer. Ann Intern Med. 1980 Jul;93(1):109–114. doi: 10.7326/0003-4819-93-1-109. [DOI] [PubMed] [Google Scholar]
  22. Velez de la Calle J. F., Jégou B. Protection by steroid contraceptives against procarbazine-induced sterility and genotoxicity in male rats. Cancer Res. 1990 Feb 15;50(4):1308–1315. [PubMed] [Google Scholar]
  23. Ward J. A., Robinson J., Furr B. J., Shalet S. M., Morris I. D. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist. Cancer Res. 1990 Feb 1;50(3):568–574. [PubMed] [Google Scholar]
  24. Waxman J. Preserving fertility in Hodgkin's disease. Baillieres Clin Haematol. 1987 Mar;1(1):185–190. doi: 10.1016/s0950-3536(87)80050-1. [DOI] [PubMed] [Google Scholar]
  25. Weissenberg R., Dar Y., Lunenfeld B. The effect of clomiphene citrate and its Zu or En isomers on the reproductive system of the immature male rat. Andrologia. 1992 May-Jun;24(3):161–165. doi: 10.1111/j.1439-0272.1992.tb02631.x. [DOI] [PubMed] [Google Scholar]
  26. Whitehead E., Shalet S. M., Blackledge G., Todd I., Crowther D., Beardwell C. G. The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer. 1982 Feb 1;49(3):418–422. doi: 10.1002/1097-0142(19820201)49:3<418::aid-cncr2820490304>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  27. da Cunha M. F., Meistrich M. L., Nader S. Absence of testicular protection by a gonadotropin-releasing hormone analogue against cyclophosphamide-induced testicular cytotoxicity in the mouse. Cancer Res. 1987 Feb 15;47(4):1093–1097. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES